Healthcare Global Enterprises: Healthcare Global (Kenya) Private Limited, a step-down subsidiary of the Company has today, i.e
Healthcare Global Enterprises (HCG) filed a disclosure titled "Healthcare Global (Kenya) Private Limited, a step-down subsidiary of the Company has today, i.e". The company is valued at about ₹9,985 crore.
What happened
Healthcare Global Enterprises (HCG) filed a disclosure with the exchanges on 5 October 2026 at 07:17 PM titled "Healthcare Global (Kenya) Private Limited, a step-down subsidiary of the Company has today, i.e".
Company snapshot
Healthcare Global Enterprises is a small-cap company in the Healthcare sector, with a market value of about ₹9,985 crore.
The stock last traded at ₹668.8, against a 52-week range of ₹513.3–₹804.7 (16.9% below the high).
Before this filing the shares had moved −4.4% over the month and +2.5% over three months. Average daily turnover over the last 20 sessions was about ₹8.64 crore.
Promoters held 64.21% at the end of Q1 FY27; 5.17% of promoter shares were pledged. Foreign institutions owned 2.74% and domestic institutions 19.20%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 613 | 4.8 | 0.34 |
| Q2 FY26 | 647 | 16.3 | 1.16 |
| Q3 FY26 | 633 | -9.4 | -0.68 |
| Q4 FY26 | 652 | 2.2 | 0.15 |
| Q1 FY27 | 695 | 13.8 | 0.92 |
What history shows
BCEIE's records show 2 previous m&a filings from the company since May 2026.
After those filings, the stock gained 3.2% on average the next trading day and was up 7.4% on average after five days (2 filings with price data).
Across 129 similar disclosures by other Healthcare companies, shares moved +0.7% on average the next day and +0.9% over five days; 60% of them rose the next day.
Market-wide, 1,961 m&a filings with an impact score of 50 or more saw an average next-day move of +0.4%, with 49% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 6 Aug 2026 | M&A | +5.5% | +5.3% |
| 4 Aug 2026 | Pursuant to Regulation 30 of the SEBI (Listing Obligations and… | +0.9% | +9.6% |
What to watch
- Regulatory approvals, completion of the deal and its effect on revenue and margins.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.